Workflow
JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Jasper TherapeuticsJasper Therapeutics(US:JSPR) Businesswireยท2025-09-21 19:59

Core Viewpoint - Investors in Jasper Therapeutics, Inc. have the opportunity to lead a securities fraud lawsuit against the company with the Schall Law Firm [1] Group 1 - The lawsuit is centered around allegations of securities fraud involving Jasper Therapeutics, Inc. [1] - The Schall Law Firm is actively seeking investors to participate in the lawsuit [1]